questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzazépines
Benzazépines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Genetic Predisposition to Disease
Diagnostic
5
Dépendance aux médicaments
Benzodiazépines
Tests de dépistage
Benzodiazépines
Trouble d'usage de substances
Benzodiazépines
Effets secondaires
Benzodiazépines
Symptômes
5
Symptômes
Benzodiazépines
Effets à long terme
Benzodiazépines
Troubles de la mémoire
Benzodiazépines
Prévention
5
Prévention
Dépendance aux médicaments
Recommandations
Benzodiazépines
Éducation des patients
Benzodiazépines
Auto-médication
Benzodiazépines
Réduction de l'usage
Benzodiazépines
Traitements
5
Prescription
Benzodiazépines
Suivi médical
Benzodiazépines
Complications
5
Complications
Benzodiazépines
Dépression respiratoire
Benzodiazépines
Interactions médicamenteuses
Benzodiazépines
Grossesse
Benzodiazépines
Facteurs de risque
5
Dépendance
Benzodiazépines
Personnes âgées
Benzodiazépines
Usage prolongé
Benzodiazépines
Facteurs psychologiques
Benzodiazépines
Interactions médicamenteuses
Benzodiazépines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzazépines : Questions médicales les plus fréquentes",
"headline": "Benzazépines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzazépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-14",
"dateModified": "2025-05-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzazépines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzodiazépines",
"alternateName": "Benzodiazepines",
"url": "https://questionsmedicales.fr/mesh/D001569",
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépines",
"code": {
"@type": "MedicalCode",
"code": "D001569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alprazolam",
"alternateName": "Alprazolam",
"url": "https://questionsmedicales.fr/mesh/D000525",
"about": {
"@type": "MedicalCondition",
"name": "Alprazolam",
"code": {
"@type": "MedicalCode",
"code": "D000525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Benzodiazépinones",
"alternateName": "Benzodiazepinones",
"url": "https://questionsmedicales.fr/mesh/D001570",
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépinones",
"code": {
"@type": "MedicalCode",
"code": "D001570",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromazépam",
"alternateName": "Bromazepam",
"url": "https://questionsmedicales.fr/mesh/D001960",
"about": {
"@type": "MedicalCondition",
"name": "Bromazépam",
"code": {
"@type": "MedicalCode",
"code": "D001960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonazépam",
"alternateName": "Clonazepam",
"url": "https://questionsmedicales.fr/mesh/D002998",
"about": {
"@type": "MedicalCondition",
"name": "Clonazépam",
"code": {
"@type": "MedicalCode",
"code": "D002998",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dévazépide",
"alternateName": "Devazepide",
"url": "https://questionsmedicales.fr/mesh/D020109",
"about": {
"@type": "MedicalCondition",
"name": "Dévazépide",
"code": {
"@type": "MedicalCode",
"code": "D020109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazépam",
"alternateName": "Diazepam",
"url": "https://questionsmedicales.fr/mesh/D003975",
"about": {
"@type": "MedicalCondition",
"name": "Diazépam",
"code": {
"@type": "MedicalCode",
"code": "D003975",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flumazénil",
"alternateName": "Flumazenil",
"url": "https://questionsmedicales.fr/mesh/D005442",
"about": {
"@type": "MedicalCondition",
"name": "Flumazénil",
"code": {
"@type": "MedicalCode",
"code": "D005442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flunitrazépam",
"alternateName": "Flunitrazepam",
"url": "https://questionsmedicales.fr/mesh/D005445",
"about": {
"@type": "MedicalCondition",
"name": "Flunitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D005445",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flurazépam",
"alternateName": "Flurazepam",
"url": "https://questionsmedicales.fr/mesh/D005479",
"about": {
"@type": "MedicalCondition",
"name": "Flurazépam",
"code": {
"@type": "MedicalCode",
"code": "D005479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lorazépam",
"alternateName": "Lorazepam",
"url": "https://questionsmedicales.fr/mesh/D008140",
"about": {
"@type": "MedicalCondition",
"name": "Lorazépam",
"code": {
"@type": "MedicalCode",
"code": "D008140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrazépam",
"alternateName": "Nitrazepam",
"url": "https://questionsmedicales.fr/mesh/D009567",
"about": {
"@type": "MedicalCondition",
"name": "Nitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D009567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépam",
"alternateName": "Oxazepam",
"url": "https://questionsmedicales.fr/mesh/D010076",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépam",
"code": {
"@type": "MedicalCode",
"code": "D010076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.663"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pirenzépine",
"alternateName": "Pirenzepine",
"url": "https://questionsmedicales.fr/mesh/D010890",
"about": {
"@type": "MedicalCondition",
"name": "Pirenzépine",
"code": {
"@type": "MedicalCode",
"code": "D010890",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prazépam",
"alternateName": "Prazepam",
"url": "https://questionsmedicales.fr/mesh/D011222",
"about": {
"@type": "MedicalCondition",
"name": "Prazépam",
"code": {
"@type": "MedicalCode",
"code": "D011222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Témazépam",
"alternateName": "Temazepam",
"url": "https://questionsmedicales.fr/mesh/D013693",
"about": {
"@type": "MedicalCondition",
"name": "Témazépam",
"code": {
"@type": "MedicalCode",
"code": "D013693",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.880"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Bromazépam",
"alternateName": "Bromazepam",
"url": "https://questionsmedicales.fr/mesh/D001960",
"about": {
"@type": "MedicalCondition",
"name": "Bromazépam",
"code": {
"@type": "MedicalCode",
"code": "D001960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonazépam",
"alternateName": "Clonazepam",
"url": "https://questionsmedicales.fr/mesh/D002998",
"about": {
"@type": "MedicalCondition",
"name": "Clonazépam",
"code": {
"@type": "MedicalCode",
"code": "D002998",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dévazépide",
"alternateName": "Devazepide",
"url": "https://questionsmedicales.fr/mesh/D020109",
"about": {
"@type": "MedicalCondition",
"name": "Dévazépide",
"code": {
"@type": "MedicalCode",
"code": "D020109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazépam",
"alternateName": "Diazepam",
"url": "https://questionsmedicales.fr/mesh/D003975",
"about": {
"@type": "MedicalCondition",
"name": "Diazépam",
"code": {
"@type": "MedicalCode",
"code": "D003975",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flumazénil",
"alternateName": "Flumazenil",
"url": "https://questionsmedicales.fr/mesh/D005442",
"about": {
"@type": "MedicalCondition",
"name": "Flumazénil",
"code": {
"@type": "MedicalCode",
"code": "D005442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flunitrazépam",
"alternateName": "Flunitrazepam",
"url": "https://questionsmedicales.fr/mesh/D005445",
"about": {
"@type": "MedicalCondition",
"name": "Flunitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D005445",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flurazépam",
"alternateName": "Flurazepam",
"url": "https://questionsmedicales.fr/mesh/D005479",
"about": {
"@type": "MedicalCondition",
"name": "Flurazépam",
"code": {
"@type": "MedicalCode",
"code": "D005479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lorazépam",
"alternateName": "Lorazepam",
"url": "https://questionsmedicales.fr/mesh/D008140",
"about": {
"@type": "MedicalCondition",
"name": "Lorazépam",
"code": {
"@type": "MedicalCode",
"code": "D008140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrazépam",
"alternateName": "Nitrazepam",
"url": "https://questionsmedicales.fr/mesh/D009567",
"about": {
"@type": "MedicalCondition",
"name": "Nitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D009567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépam",
"alternateName": "Oxazepam",
"url": "https://questionsmedicales.fr/mesh/D010076",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépam",
"code": {
"@type": "MedicalCode",
"code": "D010076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.663"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pirenzépine",
"alternateName": "Pirenzepine",
"url": "https://questionsmedicales.fr/mesh/D010890",
"about": {
"@type": "MedicalCondition",
"name": "Pirenzépine",
"code": {
"@type": "MedicalCode",
"code": "D010890",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prazépam",
"alternateName": "Prazepam",
"url": "https://questionsmedicales.fr/mesh/D011222",
"about": {
"@type": "MedicalCondition",
"name": "Prazépam",
"code": {
"@type": "MedicalCode",
"code": "D011222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Témazépam",
"alternateName": "Temazepam",
"url": "https://questionsmedicales.fr/mesh/D013693",
"about": {
"@type": "MedicalCondition",
"name": "Témazépam",
"code": {
"@type": "MedicalCode",
"code": "D013693",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.880"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlordiazépoxyde",
"alternateName": "Chlordiazepoxide",
"url": "https://questionsmedicales.fr/mesh/D002707",
"about": {
"@type": "MedicalCondition",
"name": "Chlordiazépoxyde",
"code": {
"@type": "MedicalCode",
"code": "D002707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clobazam",
"alternateName": "Clobazam",
"url": "https://questionsmedicales.fr/mesh/D000078306",
"about": {
"@type": "MedicalCondition",
"name": "Clobazam",
"code": {
"@type": "MedicalCode",
"code": "D000078306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.165"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clorazépate dipotassique",
"alternateName": "Clorazepate Dipotassium",
"url": "https://questionsmedicales.fr/mesh/D003009",
"about": {
"@type": "MedicalCondition",
"name": "Clorazépate dipotassique",
"code": {
"@type": "MedicalCode",
"code": "D003009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.180"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Estazolam",
"alternateName": "Estazolam",
"url": "https://questionsmedicales.fr/mesh/D004949",
"about": {
"@type": "MedicalCondition",
"name": "Estazolam",
"code": {
"@type": "MedicalCode",
"code": "D004949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Médazépam",
"alternateName": "Medazepam",
"url": "https://questionsmedicales.fr/mesh/D008472",
"about": {
"@type": "MedicalCondition",
"name": "Médazépam",
"code": {
"@type": "MedicalCode",
"code": "D008472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Midazolam",
"alternateName": "Midazolam",
"url": "https://questionsmedicales.fr/mesh/D008874",
"about": {
"@type": "MedicalCondition",
"name": "Midazolam",
"code": {
"@type": "MedicalCode",
"code": "D008874",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Olanzapine",
"alternateName": "Olanzapine",
"url": "https://questionsmedicales.fr/mesh/D000077152",
"about": {
"@type": "MedicalCondition",
"name": "Olanzapine",
"code": {
"@type": "MedicalCode",
"code": "D000077152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.738"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Triazolam",
"alternateName": "Triazolam",
"url": "https://questionsmedicales.fr/mesh/D014229",
"about": {
"@type": "MedicalCondition",
"name": "Triazolam",
"code": {
"@type": "MedicalCode",
"code": "D014229",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Diltiazem",
"alternateName": "Diltiazem",
"url": "https://questionsmedicales.fr/mesh/D004110",
"about": {
"@type": "MedicalCondition",
"name": "Diltiazem",
"code": {
"@type": "MedicalCode",
"code": "D004110",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fénoldopam",
"alternateName": "Fenoldopam",
"url": "https://questionsmedicales.fr/mesh/D018818",
"about": {
"@type": "MedicalCondition",
"name": "Fénoldopam",
"code": {
"@type": "MedicalCode",
"code": "D018818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Galantamine",
"alternateName": "Galantamine",
"url": "https://questionsmedicales.fr/mesh/D005702",
"about": {
"@type": "MedicalCondition",
"name": "Galantamine",
"code": {
"@type": "MedicalCode",
"code": "D005702",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.525"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ivabradine",
"alternateName": "Ivabradine",
"url": "https://questionsmedicales.fr/mesh/D000077550",
"about": {
"@type": "MedicalCondition",
"name": "Ivabradine",
"code": {
"@type": "MedicalCode",
"code": "D000077550",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.801"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol",
"alternateName": "2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine",
"url": "https://questionsmedicales.fr/mesh/D015647",
"about": {
"@type": "MedicalCondition",
"name": "1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol",
"code": {
"@type": "MedicalCode",
"code": "D015647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.838"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tolvaptan",
"alternateName": "Tolvaptan",
"url": "https://questionsmedicales.fr/mesh/D000077602",
"about": {
"@type": "MedicalCondition",
"name": "Tolvaptan",
"code": {
"@type": "MedicalCode",
"code": "D000077602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzazépines",
"alternateName": "Benzazepines",
"code": {
"@type": "MedicalCode",
"code": "D001552",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bernhard Wünsch",
"url": "https://questionsmedicales.fr/author/Bernhard%20W%C3%BCnsch",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany."
}
},
{
"@type": "Person",
"name": "Dirk Schepmann",
"url": "https://questionsmedicales.fr/author/Dirk%20Schepmann",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany."
}
},
{
"@type": "Person",
"name": "Simon M Ametamey",
"url": "https://questionsmedicales.fr/author/Simon%20M%20Ametamey",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland simon.ametamey@pharma.ethz.ch."
}
},
{
"@type": "Person",
"name": "Nadine Ritter",
"url": "https://questionsmedicales.fr/author/Nadine%20Ritter",
"affiliation": {
"@type": "Organization",
"name": "Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de."
}
},
{
"@type": "Person",
"name": "Guiscard Seebohm",
"url": "https://questionsmedicales.fr/author/Guiscard%20Seebohm",
"affiliation": {
"@type": "Organization",
"name": "Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37175659",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24097955"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36271292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22711-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37951650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mcna.2023.05.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition to cancers in children and adolescents.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36354292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOP.0000000000001197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2-sample Mendelian randomization study.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36890668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14624"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzazépines",
"item": "https://questionsmedicales.fr/mesh/D001552"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzazépines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzazépines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzazépines",
"description": "Comment diagnostiquer une dépendance aux benzazépines ?\nQuels tests sont utilisés pour évaluer l'usage des benzazépines ?\nQuels critères DSM sont liés aux benzazépines ?\nComment évaluer les effets secondaires des benzazépines ?\nQuels signes indiquent une surdose de benzazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzazépines",
"description": "Quels sont les symptômes d'une surconsommation de benzazépines ?\nComment se manifeste le sevrage des benzazépines ?\nQuels effets à long terme des benzazépines ?\nQuels symptômes d'anxiété peuvent être soulagés par les benzazépines ?\nLes benzazépines causent-elles des troubles de la mémoire ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzazépines",
"description": "Comment prévenir la dépendance aux benzazépines ?\nQuelles sont les recommandations pour l'utilisation des benzazépines ?\nComment éduquer les patients sur les benzazépines ?\nQuels sont les risques d'auto-médication avec des benzazépines ?\nComment réduire l'usage des benzazépines dans la population ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzazépines",
"description": "Comment sont prescrites les benzazépines ?\nQuelles alternatives aux benzazépines pour l'anxiété ?\nComment gérer une overdose de benzazépines ?\nLes benzazépines sont-elles efficaces pour l'insomnie ?\nQuel suivi est nécessaire lors de l'utilisation de benzazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzazépines",
"description": "Quelles complications peuvent survenir avec les benzazépines ?\nLes benzazépines augmentent-elles le risque de chutes ?\nComment les benzazépines affectent-elles la respiration ?\nLes benzazépines peuvent-elles interagir avec d'autres médicaments ?\nQuels sont les effets des benzazépines sur la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzazépines",
"description": "Quels facteurs augmentent le risque de dépendance aux benzazépines ?\nLes personnes âgées sont-elles plus à risque avec les benzazépines ?\nComment l'usage prolongé de benzazépines affecte-t-il le risque ?\nQuels facteurs psychologiques influencent l'usage des benzazépines ?\nLes interactions médicamenteuses augmentent-elles les risques ?",
"url": "https://questionsmedicales.fr/mesh/D001552?mesh_terms=Genetic+Predisposition+to+Disease#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux benzazépines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'utilisation, les symptômes de sevrage et les comportements compulsifs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'usage des benzazépines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage de drogues et des évaluations psychologiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont liés aux benzazépines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères DSM-5 pour le trouble d'usage de substances s'appliquent aux benzazépines."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets secondaires des benzazépines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'observation des symptômes et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de benzazépines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, somnolence excessive, et dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surconsommation de benzazépines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent somnolence, confusion, et troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage des benzazépines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer anxiété, insomnie, tremblements et convulsions."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des benzazépines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles cognitifs et une dépendance."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'anxiété peuvent être soulagés par les benzazépines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les benzazépines soulagent l'anxiété, les crises de panique et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les benzazépines causent-elles des troubles de la mémoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles de la mémoire, surtout à forte dose."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépendance aux benzazépines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter la durée de prescription et surveiller l'utilisation sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour l'utilisation des benzazépines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser à la dose minimale efficace et pour la durée la plus courte possible."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les benzazépines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les risques, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'auto-médication avec des benzazépines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'auto-médication peut entraîner des surdoses, des dépendances et des interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment réduire l'usage des benzazépines dans la population ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Promouvoir des alternatives thérapeutiques et sensibiliser aux risques associés."
}
},
{
"@type": "Question",
"name": "Comment sont prescrites les benzazépines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont prescrites pour des périodes courtes, généralement moins de 4 semaines."
}
},
{
"@type": "Question",
"name": "Quelles alternatives aux benzazépines pour l'anxiété ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs, thérapies cognitives et techniques de relaxation sont des alternatives."
}
},
{
"@type": "Question",
"name": "Comment gérer une overdose de benzazépines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'overdose nécessite une attention médicale immédiate, souvent avec des antidotes comme le flumazénil."
}
},
{
"@type": "Question",
"name": "Les benzazépines sont-elles efficaces pour l'insomnie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont efficaces à court terme, mais peuvent entraîner une dépendance et des effets secondaires."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire lors de l'utilisation de benzazépines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour évaluer l'efficacité et surveiller les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les benzazépines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépendance, les troubles cognitifs et les accidents liés à la somnolence."
}
},
{
"@type": "Question",
"name": "Les benzazépines augmentent-elles le risque de chutes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent le risque de chutes, surtout chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment les benzazépines affectent-elles la respiration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent déprimer le système respiratoire, surtout en cas de surdose."
}
},
{
"@type": "Question",
"name": "Les benzazépines peuvent-elles interagir avec d'autres médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent interagir avec des opioïdes, des antidépresseurs et d'autres sédatifs."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des benzazépines sur la grossesse ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent causer des malformations congénitales et des complications néonatales."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance aux benzazépines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de l'usage de substances et les troubles mentaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec les benzazépines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus sensibles aux effets sédatifs et aux risques de chutes."
}
},
{
"@type": "Question",
"name": "Comment l'usage prolongé de benzazépines affecte-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé augmente le risque de dépendance et de troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels facteurs psychologiques influencent l'usage des benzazépines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété, la dépression et le stress peuvent inciter à l'usage des benzazépines."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses augmentent-elles les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent intensifier les effets sédatifs et augmenter le risque d'accidents."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/05/2025
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany.
7 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany.
5 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland simon.ametamey@pharma.ethz.ch.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de.
Chembion, University of Münster, 48149, Münster, Germany. nadine.ritter@uni-muenster.de.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Chembion, University of Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
3 publications dans cette catégorie
Affiliations :
Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Chembion, University of Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Functionalized Molecular Solids, Ministry of Education, Anhui Key Laboratory of Molecule-Based Materials, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui 241000, China.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. Electronic address: arai.yoshikazu.mh@daiichisankyo.co.jp.
Publications dans "Benzazépines" :
2 publications dans cette catégorie
Affiliations :
End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
Publications dans "Benzazépines" :
Alzheimer's disease (AD) is a prevalent type of dementia in elderly populations with a significant genetic component. The accumulating evidence suggests that AD involves a reconfiguration of the epige...
Autoimmune diseases and coronavirus disease 2019 (COVID-19) share many similarities. Concerns have arisen that autoimmune diseases may increase the susceptibility and severity of COVID-19. We used Men...
Hemophagocytic lymphohistiocytosis (HLH) is a disorder of impaired immune regulation resulting in hyperinflammation that is ultimately fatal if not treated. HLH is categorized into familial disease, c...
Childhood cancer is rare, but it remains the leading cause of disease-related mortality among children 1-14 years of age. As exposure to environmental factors is lower in children, inherited genetic f...
Current literature suggests that 10-18% of paediatric cancer patients have an underlying genetic susceptibility to their disease. With better knowledge and technology, more genes and syndromes are bei...
This review summarizes the current knowledge about different cancer predisposition syndromes, focusing on the diagnosis, genetic counselling, surveillance and future directions....
The causalities between the coronavirus disease 2019 (COVID-19) and the risk of rheumatic diseases remain unclear. The purpose of this study was to investigate the causal effect of COVID-19 on rheumat...
Single nucleotide polymorphisms (SNPs), acquired from published genome-wide association studies, were used to perform 2-sample Mendelian randomization (MR) on cases diagnosed with COVID-19 (n = 13 464...
The results revealed a causality between COVID-19 and rheumatic diseases with an odds ratio (OR) of 1.010 (95% confidence interval [CI], 1.006-1.013; P = .014). In addition, we observed that COVID-19 ...
This is the first study to use MR to explore the impact of COVID-19 on rheumatic diseases. From a genetic perspective, we found that COVID-19 could increase the risk of rheumatic diseases, such as PBC...
Diets rich in plant-based foods are associated with lower risks of non-alcoholic fatty liver disease (NAFLD), while the prospective evidence is limited. We aimed to examine longitudinal associations o...
This longitudinal cohort study included 159,222 participants (58.0 ± 8.0 years old, 55.7% female) free of NAFLD in the UK Biobank. We calculated the overall plant-based diet index (PDI), the healthful...
During a median follow-up of 9.5 years, 1541 new-onset NAFLD cases were documented. Compared to the lowest quintile, multivariable-adjusted hazard ratios (HRs) of NAFLD in the highest quintile were 0....
Higher intake of plant-based diets especially healthful plant-based diets was associated with lower NAFLD risk and liver fat content regardless of genetic susceptibility, whereas an unhealthful plant-...
Accumulating evidence has indicated that persistent human cytomegalovirus (HCMV) infection is associated with several cardiovascular diseases including atherosclerosis and coronary artery disease. How...
Single-nucleotide polymorphisms associated with anti-cytomegalovirus immunoglobulin (Ig) G levels were used as instrumental variables to estimate the causal effect of anti-cytomegalovirus IgG levels o...
In the IVW analysis, genetically predicted anti-cytomegalovirus IgG levels were suggestively associated with coronary artery disease with an odds ratio (OR) of 1.076 [95% CI, 1.009-1.147; p = 0.025], ...
Our findings first provide direct evidence that genetic predisposition of anti-cytomegalovirus IgG levels increases the risk of coronary artery disease, peripheral artery disease, and deep vein thromb...
The implementation of next-generation sequencing technologies has provided a sharp picture of the genetic variability in the components and regulators of the alternative pathway (AP) of the complement...
Current evidence on the relations of residential greenness with glucose homeostasis and type 2 diabetes (T2D) remained largely uncertain. Most importantly, no prior studies have investigated whether g...
We leveraged data from the UK Biobank prospective cohort study, with participants enrolled between 2006 and 2010. Residential greenness was assessed by using the Normalized Difference Vegetation Index...
Among 315,146 individuals (mean [SD] age, 56.59 [8.09] years), each one-unit increase in residential greenness was associated with reduction in HbA...
We add novel evidence that residential greenness has protective effects on glucose metabolism and T2D, and those beneficial effects can be amplified by low genetic risk. Our findings may facilitate th...
Thyroid hormones have actions on cartilage, whereas the association between thyroid hormone related diseases and osteoarthritis (OA) are unclear. This study aims to investigate the association between...
Summary-level genetic data of thyrotoxicosis were obtained from FinnGen cohorts (nCase = 10,569, nControl = 762,037). Summary-level data of OA were obtained from a large-scale genome-wide association ...
Genetic predisposition of thyrotoxicosis was associated with the onset of knee OA (autoimmune hyperthyroidism: odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1.03-1.07, FDR < 0.001; thyrotoxicos...
This study provides MR evidence supporting causal association of thyrotoxicosis with knee OA in European population, whereas OA may have no causal effects on thyrotoxicosis....